NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Celea Therapeutics

Celea Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.celeatx.com/

Last Round

Seed

Jul 2, 2026

Est. Valuation

$302.5M

Total Funding Raised

$180M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Celea Therapeutics is a drug discovery company developing therapies for the treatment of respiratory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

idiopathic pulmonary fibrosisIPF treatmentdeupirfenidoneIPFdeuterated drugclinical stage biopharmarespiratory disease treatmentbiopharmasmall molecule drugorphan drugphase 3 trialdrug developmentpipeline drugdrug reformulationfibrotic lung diseasedrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celea Therapeutics Comparables

Compare Celea Therapeutics with similar companies based on industry and business-model similarity.

Celea Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avalyn Pharma
88%
Endeavor Biomedicines
80%
Oorja Bio, Inc.
79%

Celea Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 2, 2026
VC RoundApr 29, 2026
SpinoffAug 12, 2025

Celea Therapeutics Investors

Notable investors and investment history

Celea Therapeutics investors
InvestorRounds
RA Capital ManagementSeed
PureTech HealthSeed, VC Round, Spinoff

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $180M round with participation from Leaps by Bayer.

  • Apr 29, 2026

    PureTech Health participated in a VC Round.

Celea Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Celea Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celea Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2025
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.